Phio Pharmaceuticals (PHIO) Stock Analysis: AI Score & Alternative Data
PHIO alt-data: headcount climbing, web traffic lagging
Is Phio Pharmaceuticals a buy right now? The alternative data says hold. This PHIO stock analysis is built on the 25+ alternative data signals AltIndex tracks on Phio Pharmaceuticals every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 55/100: a Hold. The stock trades at $0.87 with a $11M market cap.
The bullish side of the 90-day ledger: headcount (according to LinkedIn) up 5.9% to 18 employees, and sentiment up 6.5% to 66/100. The drag: web traffic down 12.0% to 5K monthly visits. That tension is what keeps the score mid-range.
PHIO’s broader alt-data profile also covers YouTube subscribers (35). Every signal links to its own page with full history, the PHIO technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on PHIO is just below.
Phio Pharmaceuticals AI Stock Analysis
Phio Pharmaceuticals is a biotechnology company focused on developing innovative therapies based on its proprietary self-delivering RNAi (INTASYL™) technology. The company’s primary aim is to develop treatments that improve the lives of patients suffering from cancer and other debilitating diseases.
Analysis generated September 29, 2026.
Recent Phio Pharmaceuticals Stock Alerts
|
Phio Pharmaceuticals | October 12 Price is down by -7% in the last 24h. |
|
Phio Pharmaceuticals | September 27 Insider Alert: BRADFORD PATRICIA A is buying shares |
|
Phio Pharmaceuticals | September 24 Insider Alert: Bitterman Robert J is buying shares |
|
Phio Pharmaceuticals | August 27 Price is down by -6.7% in the last 24h. |
Phio Pharmaceuticals Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 5K | 12.0% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 18 | 5.9% | |
| Wikipedia Views | 1 | 0% | |
| Sentiment | 66 | 6.5% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 56 | N/A | |
| Stocktwits Mentions | 6 | 91.5% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 19K | N/A | |
| Youtube Subscribers | 35 | N/A |
About Phio Pharmaceuticals (PHIO)
Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
| Price | $0.87 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $11M |
| Year Range | $1 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Phio Pharmaceuticals News
View more → |
Checkpoint Inhibitor Refractory Cancer Market Outlook is Predicted to Improve by 2036, Biopharma Companies Advance Novel Immuno-Oncology Candidates | DelveInsightAugust 19 - PRNewswire |
See Phio Pharmaceuticals’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for PHIO, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEPhio Pharmaceuticals Earnings & Financial Performance
View all earnings →Phio Pharmaceuticals Insider Trading Activity
View all →| BRADFORD PATRICIA A filed to sell 64,151 shares at $0.0. Sep 24 '26 |
| Bitterman Robert J filed to sell 364,871 shares at $0.0. Sep 22 '26 |
| BRADFORD PATRICIA A filed to sell 57,651 shares at $0.0. Sep 15 '26 |
| Plott Ronald Todd filed to sell 15,000 shares at $0.0. Aug 19 '26 |
| Bitterman Robert J filed to sell 431,421 shares at $0.0. Aug 18 '26 |
Phio Pharmaceuticals Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Phio Pharmaceuticals
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Tempest TherapeuticsTPST |
$0.62 1.7% | $11M | 43 |
 |
Kiora PharmaceuticalsKPRX |
$2.40 0.4% | $11M | 57 |
 |
Intensity TherapeuticsINTS |
$3.35 0.9% | $11M | 52 |
 |
AEON BiopharmaAEON |
$0.23 4.5% | $11M | 46 |
 |
Lantern PharmaLTRN |
$0.67 0.2% | $10M | 40 |
Explore Phio Pharmaceuticals Data
Frequently Asked Questions: Phio Pharmaceuticals (PHIO)
Phio Pharmaceuticals has an AltIndex AI Score of 55/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
55/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Phio Pharmaceuticals (PHIO) stock is $0.87 with a market cap of $11M.
As of today, Phio Pharmaceuticals’s PE (Price to Earnings) ratio is —.
View the latest Phio Pharmaceuticals insider transactions to see recent buying and selling activity by company executives and directors.
Check the Phio Pharmaceuticals congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The PHIO stock price chart above shows Phio Pharmaceuticals’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Phio Pharmaceuticals technical analysis for RSI, moving averages, and more.
See the stocks similar to Phio Pharmaceuticals section on this page for companies in the same industry ranked by market cap and AI Score.
